Burkhart Erin

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 10 of 10 of 10 of 10 of 1

BioMarin Pharmaceutical Inc.

Drugs » Biotechnology

GVP, Chief Accounting Officer:

Holdings: 16.16K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

($205.74K) Net Amount
Buy:0--
Sell:($205.74K)$90.00